EYELID SKIN APPLICATION EXTENDS DELIVERY OF DRUGS IN THE EYEBALL
- In: What’s new in industry and science? Part 1 on Monday, 23 September 2019, 15:20-15:30
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Presentation
- By: SEE, Gerard Lee (Josai University, Pharmaceutical Sciences, Japan)
- Co-author(s): Gerard Lee Lo See: Graduate School of Pharmaceutical Sciences, Josai University, Sakado, Japan;Department of Pharmacy, University of San Carlos, Cebu, Philippines
Shoko Itakura: Graduate School of Pharmaceutical Sciences, Josai University, Sakado, Japan
Hiroaki Todo: Graduate School of Pharmaceutical Sciences, Josai University, Sakado, Japan
Konstanty Wierzba: Graduate School of Pharmaceutical Sciences, Josai University, Sakado, Japan
Kenji Sugibayashi: Graduate School of Pharmaceutical Sciences, Josai University, Sakado, Japan - Abstract:
Background
Extending the delivery of drugs into the eyes while reducing systemic bioavailability is of utmost importance in the management of chronic ocular diseases. Topical application onto the lower eyelid skin, as an alternative to eye drops, is seen to be a valuable strategy in the treatment of chronic eye diseases.
Methods
Three methods
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023